vs
Side-by-side financial comparison of Ingevity Corp (NGVT) and Opera Ltd (OPRA). Click either name above to swap in a different company.
Ingevity Corp is the larger business by last-quarter revenue ($185.4M vs $142.7M, roughly 1.3× Opera Ltd). Opera Ltd runs the higher net margin — 12.8% vs -45.6%, a 58.4% gap on every dollar of revenue.
Ingevity Corp is a global specialty chemicals and advanced materials manufacturer. It produces high-performance carbon materials, pavement preservation solutions, and specialty chemicals, serving automotive emissions control, industrial purification, road infrastructure, and agricultural input markets across North America, Europe, and Asia Pacific.
Opera is a multinational technology corporation headquartered in Oslo, Norway, with additional offices in Europe, China, and Africa. Opera offers a range of products and services that include PC and mobile web browsers, GameMaker and gaming portals, the Opera News content recommendation products, the Opera Ads platform, and a number of Web3 and e-commerce products and services. The company's total user base is 296 million monthly active users.
NGVT vs OPRA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.4M | $142.7M |
| Net Profit | $-84.6M | $18.3M |
| Gross Margin | 41.2% | — |
| Operating Margin | -47.7% | 14.8% |
| Net Margin | -45.6% | 12.8% |
| Revenue YoY | 36.7% | — |
| Net Profit YoY | -609.6% | — |
| EPS (diluted) | $-2.33 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.4M | — | ||
| Q3 25 | $333.1M | — | ||
| Q2 25 | $365.1M | — | ||
| Q1 25 | $284.0M | $142.7M | ||
| Q4 24 | $135.6M | — | ||
| Q3 24 | $333.8M | — | ||
| Q2 24 | $390.6M | $211.6M | ||
| Q1 24 | $340.1M | — |
| Q4 25 | $-84.6M | — | ||
| Q3 25 | $43.5M | — | ||
| Q2 25 | $-146.5M | — | ||
| Q1 25 | $20.5M | $18.3M | ||
| Q4 24 | $16.6M | — | ||
| Q3 24 | $-107.2M | — | ||
| Q2 24 | $-283.7M | $34.1M | ||
| Q1 24 | $-56.0M | — |
| Q4 25 | 41.2% | — | ||
| Q3 25 | 40.2% | — | ||
| Q2 25 | 37.8% | — | ||
| Q1 25 | 39.9% | — | ||
| Q4 24 | 81.3% | — | ||
| Q3 24 | 39.4% | — | ||
| Q2 24 | 31.5% | — | ||
| Q1 24 | 29.3% | — |
| Q4 25 | -47.7% | — | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | -39.1% | — | ||
| Q1 25 | 9.4% | 14.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 33.0% | — | ||
| Q2 24 | 25.9% | 19.6% | ||
| Q1 24 | 22.6% | — |
| Q4 25 | -45.6% | — | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | -40.1% | — | ||
| Q1 25 | 7.2% | 12.8% | ||
| Q4 24 | 12.2% | — | ||
| Q3 24 | -32.1% | — | ||
| Q2 24 | -72.6% | 16.1% | ||
| Q1 24 | -16.5% | — |
| Q4 25 | $-2.33 | — | ||
| Q3 25 | $1.18 | — | ||
| Q2 25 | $-4.02 | — | ||
| Q1 25 | $0.56 | — | ||
| Q4 24 | $0.44 | — | ||
| Q3 24 | $-2.94 | — | ||
| Q2 24 | $-7.81 | — | ||
| Q1 24 | $-1.54 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | — |
| Total DebtLower is stronger | $1.2B | — |
| Stockholders' EquityBook value | $29.7M | — |
| Total Assets | $1.7B | — |
| Debt / EquityLower = less leverage | 39.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.1M | — | ||
| Q3 25 | $83.4M | — | ||
| Q2 25 | $76.9M | — | ||
| Q1 25 | $71.5M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $135.5M | — | ||
| Q2 24 | $107.4M | — | ||
| Q1 24 | $88.5M | — |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $29.7M | — | ||
| Q3 25 | $138.1M | — | ||
| Q2 25 | $120.7M | — | ||
| Q1 25 | $234.6M | — | ||
| Q4 24 | $195.2M | — | ||
| Q3 24 | $214.5M | — | ||
| Q2 24 | $284.8M | — | ||
| Q1 24 | $568.2M | — |
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.3B | — | ||
| Q1 24 | $2.6B | — |
| Q4 25 | 39.10× | — | ||
| Q3 25 | 8.39× | — | ||
| Q2 25 | 10.24× | — | ||
| Q1 25 | 5.68× | — | ||
| Q4 24 | 6.86× | — | ||
| Q3 24 | 6.52× | — | ||
| Q2 24 | 4.92× | — | ||
| Q1 24 | 2.48× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $97.1M | — |
| Free Cash FlowOCF − Capex | $73.5M | — |
| FCF MarginFCF / Revenue | 39.6% | — |
| Capex IntensityCapex / Revenue | 12.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $273.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.1M | — | ||
| Q3 25 | $129.7M | — | ||
| Q2 25 | $79.0M | — | ||
| Q1 25 | $25.4M | — | ||
| Q4 24 | $64.5M | — | ||
| Q3 24 | $46.5M | — | ||
| Q2 24 | $29.7M | — | ||
| Q1 24 | $-12.1M | — |
| Q4 25 | $73.5M | — | ||
| Q3 25 | $117.8M | — | ||
| Q2 25 | $66.8M | — | ||
| Q1 25 | $15.4M | — | ||
| Q4 24 | $39.6M | — | ||
| Q3 24 | $28.5M | — | ||
| Q2 24 | $11.6M | — | ||
| Q1 24 | $-28.7M | — |
| Q4 25 | 39.6% | — | ||
| Q3 25 | 35.4% | — | ||
| Q2 25 | 18.3% | — | ||
| Q1 25 | 5.4% | — | ||
| Q4 24 | 29.2% | — | ||
| Q3 24 | 8.5% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | -8.4% | — |
| Q4 25 | 12.7% | — | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 3.5% | — | ||
| Q4 24 | 18.4% | — | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | 4.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.98× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.24× | — | ||
| Q4 24 | 3.89× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NGVT
| Performance Materials | $151.2M | 82% |
| Advanced Polymer Technologies Segment | $36.5M | 20% |
OPRA
Segment breakdown not available.
